SAO PAULO, Nov. 4, 2015 /PRNewswire/ -- Ultrapar
Participacoes S.A. (BM&FBOVESPA: UGPA3 / NYSE: UGP), a
multi-business company engaged in specialized distribution and
retail (Ipiranga / Ultragaz / Extrafarma), specialty chemicals
(Oxiteno) and storage for liquid bulk (Ultracargo), hereby reports
its results for the third quarter of 2015.
Main highlights in 3Q15
- ULTRAPAR'S NET REVENUES TOTAL R$ 19
BILLION IN 3Q15, 11% GROWTH OVER 3Q14.
- ULTRAPAR'S EBITDA REACHES R$ 944
MILLION IN 3Q15, 20% GROWTH OVER 3Q14.
- SHARE REPURCHASE PROGRAM TOTALS 1.9 MILLION SHARES IN 3Q15,
REACHING 4.7 MILLION SHARES ACQUIRED IN 9M15.
"During the third quarter, the macroeconomic environment
continued to impose challenges, which we could overcome due to
consistent investments in resilient segments, to the improvement of
processes and to the offering of products and services that suit
our customer's needs. Our multi-business positioning allows us to
walk through adversity and continue to present sound results and
implement our strategic initiatives. We have just opened our first
Extrafarma drugstore in an Ipiranga service station, which marks
the beginning of a more intense process of cross-fertilization
among our specialized distribution and retail businesses."
Thilo Mannhardt – CEO
Results conference call
Brazilian conference
call/APIMEC
November 6th, 2015
09:30 a.m. (US EST)
Hotel Unique
(Tavarua room)
Sao Paulo – SP
Telephone for connection: +55 11 2188 0155
Code: Ultrapar
International conference call
November 6th, 2015
12:00 p.m. (US EST)
Participants in the USA: +1 877
317 6776
Participants in Brazil: 0800 891
0015
International participants: +1 412 317 6776
Code: Ultrapar
IR Contact
E-mail: invest@ultra.com.br
Telephone: + 55 11 3177 7014
Website: www.ultra.com.br
Ultrapar Participacoes S.A.
UGPA3 = R$ 66.80/share (09/30/15)
UGP = US$ 16.72/ADR (09/30/15)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ultrapar-announces-its-3q15-results-300172781.html
SOURCE Ultrapar Participacoes S.A.